High growth rate of benign thyroid nodules bearing RET/PTC rearrangements

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 6, 2011, Pages

  Sapio, Maria Rosaria ^a   Guerra, Anna ^a   Marotta, Vincenzo ^a   Campanile, Elisabetta ^a   Formisano, Raffaele ^a   Deandrea, Maurilio ^b   Motta, Manuela ^c   Limone, Paolo Piero ^b   Fenzi, Gianfranco ^a   Rossi, Guido ^a   Vitale, Mario ^a,d  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Presidio Ospedaliero Umberto I Ordine Mauriziano   (Italy)

^c MAURIZIANO HOSPITAL   (Italy)

^d UNIVERSITY OF SALERNO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENE REARRANGEMENT; GROWTH RATE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; ONCOGENE; ONCOGENE RET; PRIORITY JOURNAL; PROSPECTIVE STUDY; PTC GENE; THYROID NODULE; TUMOR GROWTH; TUMOR VOLUME; WILD TYPE;

ADULT; AGED; BLOTTING, SOUTHERN; FEMALE; GENE REARRANGEMENT; HUMANS; MALE; MIDDLE AGED; ONCOGENE PROTEINS, FUSION; PROSPECTIVE STUDIES; PROTO-ONCOGENE PROTEINS C-RET; THYROID NODULE;

EID: 79956306618     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-1599     Document Type: Article

References (20)

1. Hegedüs L, Bonnema SJ, Bennedbaek FN 2003 Management of simple nodular goiter: current status and future perspectives. Endocr Rev 24:102-132 (Pubitemid 36223282)
2. Santoro M, Chiappetta G, Cerrato A, Salvatore D, Zhang L, Manzo G, Picone A, Portella G, Santelli G, Vecchio G, Fusco A 1996 Development of thyroid papillary carcinomas secondary to tissue-specific expression of the RET/PTC1 oncogene in transgenic mice. Oncogene 12:1821-1826 (Pubitemid 26146307)
3. Borrello MG, Alberti L, Arighi E, Bongarzone I, Battistini C, Bardelli A, Pasini B, Piutti C, Rizzetti MG, Mondellini P, Radice MT, Pierotti MA 1996 The full oncogenic activity of Ret/ptc2 depends on tyrosine 539, a docking site for phospholipase Cγ. Mol Cell Biol 16:2151-2163 (Pubitemid 26123736)
4. Ishizaka Y, Kobayashi S, Ushijima T, Hirohashi S, Sugimura T, Nagao M 1991 Detection of retTPC/PTC transcripts in thyroid adenomas and adenomatous goiter by an RT-PCR method. Oncogene 6:1667-1672 (Pubitemid 21924271)
5. Elisei R, Romei C, Vorontsova T, Cosci B, Veremeychik V, Kuchinskaya E, Basolo F, Demidchik EP, Miccoli P, Pinchera A, Pacini F 2001 RET/PTC rearrangements in thyroid nodules: studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults. J Clin Endocrinol Metab 86:3211-3216 (Pubitemid 32673490)
6. Bounacer A, Wicker R, Caillou B, Cailleux AF, Sarasin A, Schlumberger M, Suárez HG 1997 High prevalence of activating ret protooncogene rearrangements, in thyroid tumors from patients who had received external radiation. Oncogene 15:1263-1273 (Pubitemid 27429741)
7. 2002 Fine-needle aspiration cytology (FNAC). Guidelines for the management of thyroid cancer in adults. London: Perros; 7-8
8. Marotta V, Guerra A, Sapio MR, Campanile E, Motta M, Fenzi G, Rossi G, Vitale M 2010 Growing thyroid nodules with benign histology and RET rearrangement. Endocr J 57:1081-1087
9. Melillo RM, Santoro M, Ong SH, Billaud M, Fusco A, Hadari YR, Schlessinger J, Lax I 2001 Docking protein FRS2 links the protein tyrosine kinase RET and its oncogenic forms with the mitogen-activated protein kinase signaling cascade. Mol Cell Biol 21:4177-4187 (Pubitemid 32565300)
10. Unger K, Zitzelsberger H, Salvatore G, Santoro M, Bogdanova T, Braselmann H, Kastner P, Zurnadzhy L, Tronko N, Hutzler P, Thomas G 2004 Heterogeneity in the distribution of RET/PTC rearrangements within individual post-Chernobyl papillary thyroid carcinomas. J Clin Endocrinol Metab 89:4272-4279 (Pubitemid 39244425)
11. Corvi R, Martinez-Alfaro M, Harach HR, Zini M, Papotti M, Romeo G 2001 Frequent RET rearrangements in thyroid papillary microcarcinoma detected by interphase fluorescence in situ hybridization. Lab Invest 81:1639-1645 (Pubitemid 33144426)
12. Zlotnik A, Yoshie O 2000 Chemokines: a new classification system and their role in immunity. Immunity 12:121-127 (Pubitemid 30398626)
13. Mellado M, Rodríguez-Frade JM, Mañes S, Martínez-A C 2001 Chemokine signaling and functional responses: the role of receptor dimerization and TK pathway activation. Annu Rev Immunol 19:397-421 (Pubitemid 32368041)
14. Melillo RM, Castellone MD, Guarino V, De Falco V, Cirafici AM, Salvatore G, Caiazzo F, Basolo F, Giannini R, Kruhoffer M, Orntoft T, Fusco A, Santoro M 2005 The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells. J Clin Invest 115:1068-1081 (Pubitemid 40489412)
15. Castellone MD, Guarino V, De Falco V, Carlomagno F, Basolo F, Faviana P, Kruhoffer M, Orntoft T, Russell JP, Rothstein JL, Fusco A, Santoro M, Melillo RM 2004 Functional expression of the CXCR4chemokine receptor is induced by RET/PTC oncogenes and is a common event in human papillary thyroid carcinomas. Oncogene 23:5958-5967 (Pubitemid 39093540)
16. Costante G, Crocetti U, Schifino E, Ludovico O, Capula C, Nicotera M, Arturi F, Filetti S 2004 Slow growth of benign thyroid nodules after menopause: no need for long-term thyroxine suppressive therapy in post-menopausal women. J Endocrinol Invest 27:31-36 (Pubitemid 38324716)
17. Castro MR, Caraballo PJ, Morris JC 2002 Effectiveness of thyroid hormone suppressive therapy in benign solitary thyroid nodules: a meta-analysis. J Clin Endocrinol Metab 87:4154-4159
18. Papini E, Petrucci L, Guglielmi R, Panunzi C, Rinaldi R, Bacci V, Crescenzi A, Nardi F, Fabbrini R, Pacella CM 1998 Long-term changes in nodular goiter: a 5-year prospective randomized trial of levothyroxine suppressive therapy for benign cold thyroid nodules. J Clin Endocrinol Metab 83:780-783 (Pubitemid 28496445)
19. La Rosa GL, Lupo L, Giuffrida D, Gullo D, Vigneri R, Belfiore A 1995 Levothyroxine and potassium iodide are both effective in treating benign solitary solid cold nodules of the thyroid. Ann Intern Med 122:1-8
20. Reverter JL, Lucas A, Salinas I, Audí L, Foz M, Sanmartí A 1992 Suppressive therapy with levothyroxine for solitary thyroid nodules. Clin Endocrinol (Oxf) 36:25-28